These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17549748)

  • 41. Altered mRNA splicing of dystrophin in type 1 myotonic dystrophy.
    Nakamori M; Kimura T; Fujimura H; Takahashi MP; Sakoda S
    Muscle Nerve; 2007 Aug; 36(2):251-7. PubMed ID: 17487865
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myotonic dystrophy type 2 and related myotonic disorders.
    Meola G; Moxley RT
    J Neurol; 2004 Oct; 251(10):1173-82. PubMed ID: 15503094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.
    Kuyumcu-Martinez NM; Cooper TA
    Prog Mol Subcell Biol; 2006; 44():133-59. PubMed ID: 17076268
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular Effects of the CTG Repeats in Mutant Dystrophia Myotonica Protein Kinase Gene.
    Llamusí B; Artero R
    Curr Genomics; 2008 Dec; 9(8):509-16. PubMed ID: 19516957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does proximal myotonic myopathy show anticipation?
    Kruse B; Wöhrle D; Steinbach P; Gal A
    Hum Mutat; 2008 Aug; 29(8):E100-2. PubMed ID: 18484632
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
    Meola G
    Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RNA-mediated neuromuscular disorders.
    Ranum LP; Cooper TA
    Annu Rev Neurosci; 2006; 29():259-77. PubMed ID: 16776586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Congenital myotonic dystrophy: variability in muscle involvement and histopathological process.
    Kuo HC; Huang CC; Chu CC; Wai YY; Hsiao KM; Chu NS
    Acta Neurol Taiwan; 2006 Mar; 15(1):13-20. PubMed ID: 16599279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Real-time RT-PCR for CTG repeat-containing genes.
    Eriksson M
    Methods Mol Biol; 2004; 277():77-84. PubMed ID: 15201450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The expansion of 300 CTG repeats in myotonic dystrophy transgenic mice does not induce sensory or motor neuropathy.
    Gantelet E; Kraftsik R; Delaloye S; Gourdon G; Kuntzer T; Barakat-Walter I
    Acta Neuropathol; 2007 Aug; 114(2):175-85. PubMed ID: 17318633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression.
    Margolis JM; Schoser BG; Moseley ML; Day JW; Ranum LP
    Hum Mol Genet; 2006 Jun; 15(11):1808-15. PubMed ID: 16624843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular mechanisms of muscle atrophy in myotonic dystrophies.
    Timchenko L
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2280-7. PubMed ID: 23796888
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CTG repeat instability in a human embryonic stem cell line carrying the myotonic dystrophy type 1 mutation.
    De Temmerman N; Seneca S; Van Steirteghem A; Haentjens P; Van der Elst J; Liebaers I; Sermon KD
    Mol Hum Reprod; 2008 Jul; 14(7):405-12. PubMed ID: 18577525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cognition and adaptive skills in myotonic dystrophy type 1: a study of 55 individuals with congenital and childhood forms.
    Ekström AB; Hakenäs-Plate L; Tulinius M; Wentz E
    Dev Med Child Neurol; 2009 Dec; 51(12):982-90. PubMed ID: 19459914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered signal transduction pathways and induction of autophagy in human myotonic dystrophy type 1 myoblasts.
    Beffy P; Del Carratore R; Masini M; Furling D; Puymirat J; Masiello P; Simili M
    Int J Biochem Cell Biol; 2010 Dec; 42(12):1973-83. PubMed ID: 20797447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxidative stress in myotonic dystrophy type 1.
    Toscano A; Messina S; Campo GM; Di Leo R; Musumeci O; Rodolico C; Aguennouz M; Annesi G; Messina C; Vita G
    Free Radic Res; 2005 Jul; 39(7):771-6. PubMed ID: 16036357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The correlation of CTG repeat length with material and social deprivation in myotonic dystrophy.
    Laberge L; Veillette S; Mathieu J; Auclair J; Perron M
    Clin Genet; 2007 Jan; 71(1):59-66. PubMed ID: 17204048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Myotonic dystrophies: clinical presentation, pathogenesis, diagnostics and therapy].
    Finsterer J; Rudnik-Schöneborn S
    Fortschr Neurol Psychiatr; 2015 Jan; 83(1):9-17. PubMed ID: 25602187
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fen1 does not control somatic hypermutability of the (CTG)(n)*(CAG)(n) repeat in a knock-in mouse model for DM1.
    van den Broek WJ; Nelen MR; van der Heijden GW; Wansink DG; Wieringa B
    FEBS Lett; 2006 Oct; 580(22):5208-14. PubMed ID: 16978612
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of the pattern of cognitive impairment in myotonic dystrophy type 1.
    Modoni A; Silvestri G; Pomponi MG; Mangiola F; Tonali PA; Marra C
    Arch Neurol; 2004 Dec; 61(12):1943-7. PubMed ID: 15596617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.